Compare Iovance Biotherapeutics Inc. Common Stock (IOVA) vs News Corporation Class A Common Stock (NWSA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Iovance Biotherapeutics Inc. Common Stock vs News Corporation Class A Common Stock — how do they compare? Iovance Biotherapeutics Inc. Common Stock trades at $14.92 (market cap $6.04B), while News Corporation Class A Common Stock trades at $29.04 (market cap $16.14B). The key difference: News Corporation Class A Common Stock is far larger — about 2.7× Iovance Biotherapeutics Inc. Common Stock's market cap, and News Corporation Class A Common Stock pays a 0.69% dividend while Iovance Biotherapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Iovance Biotherapeutics Inc. Common Stock for 0 Days and News Corporation Class A Common Stock for 0 Days on average.
| IOVA | NWSA | |
|---|---|---|
Market Cap | $6.04B | $16.14B |
Volume | 14,805,993 | 4,310,610 |
Sector | Health | Media |
52-Week High | $14.82 | $31.19 |
52-Week Low | $1.81 | $22.40 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $5.97B | $16.96B |
Dividend Yield | — | 0.69% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Iovance Biotherapeutics Inc. Common Stock
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →About News Corporation Class A Common Stock
News Corporation operates businesses in news and information services, digital real estate, and book publishing. Its brands include Dow Jones, The Wall Street Journal, HarperCollins, Realtor.com, and realestate.com.au.
Read more on NWSA →
